Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-28

FDA Approved: MEMANTINE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application for memantine submitted by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

SUPPL AP for MEMANTINE (MEMANTINE)